Related Experiment Video

Updated: Aug 14, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Treatment of metastatic non-small-cell lung cancer

D H Johnson1, A Sandler

  • 1Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical School, Nashville, Tennessee, USA.

Chest Surgery Clinics of North America
|March 20, 2001
PubMed

Insights

New treatments offer hope for advanced non-small cell lung cancer (NSCLC). However, preventing and quitting tobacco use remains critical for public health and combating lung cancer.

Area of Science:

  • Oncology
  • Public Health
  • Tobacco Control

Background:

  • Advanced non-small cell lung cancer (NSCLC) presents significant management challenges.
  • Despite progress in treatment, lung cancer remains a major health concern.
  • Tobacco use is a primary driver of lung cancer incidence.

Purpose of the Study:

  • To highlight advancements in treating advanced NSCLC.
  • To emphasize the urgent need for tobacco use prevention and cessation strategies.
  • To underscore the importance of public awareness regarding tobacco's dangers.

Main Methods:

  • Review of current and emerging therapeutic strategies for advanced NSCLC.
  • Analysis of the critical role of tobacco control in lung cancer prevention.
  • Discussion of the need for improved smoking cessation interventions.

Main Results:

  • New therapeutic tools are improving the outlook for advanced NSCLC patients.
  • Significant opportunities exist to leverage tumor biology knowledge for future treatments.
  • Effective tobacco prevention and cessation methods are paramount.

Conclusions:

  • While NSCLC treatment is advancing, tobacco use remains a critical public health issue.
  • Developing novel strategies to prevent tobacco uptake and aid cessation is essential.
  • Increased public recognition of tobacco-related dangers is necessary to reduce lung cancer burden.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...